{"filing":{"accession_number":"0001628280-26-052112","cik":"0001337013","ticker":"INFU","company_name":"InfuSystem Holdings, Inc","form":"8-K","filing_date":"2026-08-04","report_date":"2026-08-04","primary_document":"infu-20260804.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1337013/000162828026052112/infu-20260804.htm"},"events":[{"id":23546,"run_id":21280,"accession_number":"0001628280-26-052112","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"InfuSystem issued a press release on August 4, 2026 reporting financial results for the second quarter ended June 30, 2026, disclosing net revenues of $36.9 million (2.6% increase YoY), net income of $3.2 million ($0.15 per diluted share), and Adjusted EBITDA of $8.6 million with 23.4% margin. The press release is furnished as Exhibit 99.1 to the 8-K under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings releases. This is a material disclosure affecting investor assessment of the company's operational and financial performance.","company_name":"InfuSystem Holdings, Inc","ticker":"INFU","filing_date":"2026-08-04","form":"8-K","submitted_at":null,"items":[{"id":23803,"accession_number":"0001628280-26-052112","item_number":"2.02","item_title":"Results of Operations and Financial Condition","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"InfuSystem issued a press release on August 4, 2026 reporting financial results for the second quarter ended June 30, 2026, disclosing net revenues of $36.9 million (2.6% increase YoY), net income of $3.2 million ($0.15 per diluted share), and Adjusted EBITDA of $8.6 million with 23.4% margin. The press release is furnished as Exhibit 99.1 to the 8-K under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings releases. This is a material disclosure affecting investor assessment of the company's operational and financial performance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-04T10:33:27.470382+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":23803,"accession_number":"0001628280-26-052112","item_number":"2.02","item_title":"Results of Operations and Financial Condition","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"InfuSystem issued a press release on August 4, 2026 reporting financial results for the second quarter ended June 30, 2026, disclosing net revenues of $36.9 million (2.6% increase YoY), net income of $3.2 million ($0.15 per diluted share), and Adjusted EBITDA of $8.6 million with 23.4% margin. The press release is furnished as Exhibit 99.1 to the 8-K under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings releases. This is a material disclosure affecting investor assessment of the company's operational and financial performance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-04T10:33:27.470382+00:00","company_name":"InfuSystem Holdings, Inc","ticker":"INFU","filing_date":"2026-08-04"}]}